Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Bowlus

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
Hepatology Communications|May 10, 2024
Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trialsMichael Li, Ruth-Anne Pai, Rachel Gomel, et al.
Journal of Hepatology|June 6, 2006
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitisChristopher L Bowlus, Tom H Karlsen, Ulrika Broomé, et al.
Abdominal Radiology (New York)|October 13, 2023
Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitisErick Cruz Grave, Thomas Loehfelm, Michael T Corwin, et al.
The American Journal of Gastroenterology|May 18, 2026
Evolving Concepts of Treatment Targets for PBC: A Global PerspectiveChristopher L Bowlus, Paulo L Bittencourt, Billal Bobat, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2005
Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiencyChristopher L Bowlus, Ira Willner, Mark A Zern, et al.
Journal of Autoimmunity|July 30, 2002
Expression, genomic structure and mapping of the thymus specific protease prss16: a candidate gene for insulin dependent diabetes mellitus susceptibilitySaijai Cheunsuk, Rachel Sparks, Janice K Noveroske, et al.
Hepatology Communications|May 16, 2018
A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationaleCynthia Levy, Christopher L Bowlus, Elizabeth Carey, et al.
Clinical Therapeutics|March 24, 2007
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trialsJohn B Buse, David C Klonoff, Loretta L Nielsen, et al.
Journal of Autoimmunity|August 15, 2006
IL-2 receptor alpha deficiency and features of primary biliary cirrhosisChristopher A Aoki, Chaim M Roifman, Zhe-Xiong Lian, et al.
BMJ Open Gastroenterology|October 22, 2025
Assessment of adherence to guidelines for biochemical monitoring and ursodeoxycholic acid treatment response in a retrospective cohort of US patients with primary biliary cholangitisStuart C Gordon, Amandeep Sahota, Mark A Schmidt, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
Hepatology Communications|May 10, 2024
Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trialsMichael Li, Ruth-Anne Pai, Rachel Gomel, et al.
Journal of Hepatology|June 6, 2006
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitisChristopher L Bowlus, Tom H Karlsen, Ulrika Broomé, et al.
Abdominal Radiology (New York)|October 13, 2023
Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitisErick Cruz Grave, Thomas Loehfelm, Michael T Corwin, et al.
The American Journal of Gastroenterology|May 18, 2026
Evolving Concepts of Treatment Targets for PBC: A Global PerspectiveChristopher L Bowlus, Paulo L Bittencourt, Billal Bobat, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2005
Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiencyChristopher L Bowlus, Ira Willner, Mark A Zern, et al.
Journal of Autoimmunity|July 30, 2002
Expression, genomic structure and mapping of the thymus specific protease prss16: a candidate gene for insulin dependent diabetes mellitus susceptibilitySaijai Cheunsuk, Rachel Sparks, Janice K Noveroske, et al.
Hepatology Communications|May 16, 2018
A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationaleCynthia Levy, Christopher L Bowlus, Elizabeth Carey, et al.
Clinical Therapeutics|March 24, 2007
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trialsJohn B Buse, David C Klonoff, Loretta L Nielsen, et al.
Journal of Autoimmunity|August 15, 2006
IL-2 receptor alpha deficiency and features of primary biliary cirrhosisChristopher A Aoki, Chaim M Roifman, Zhe-Xiong Lian, et al.
BMJ Open Gastroenterology|October 22, 2025
Assessment of adherence to guidelines for biochemical monitoring and ursodeoxycholic acid treatment response in a retrospective cohort of US patients with primary biliary cholangitisStuart C Gordon, Amandeep Sahota, Mark A Schmidt, et al.
Pageof 19